Global Magnetic Particle Imaging Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Magnetic Particle Imaging Market Size

• The global magnetic particle imaging market size was valued at USD 571.6 million in 2024 and is expected to reach USD 1,667.51 million by 2032, at a CAGR of 14.32% during the forecast period
• The market growth is largely fueled by the increasing demand for highly sensitive and quantitative imaging techniques in biomedical research and clinical diagnostics, leading to enhanced visualization and characterization of tissues and biological processes
• Furthermore, rising technological advancements in hardware and software, coupled with growing research into novel contrast agents, is establishing magnetic particle imaging as a cutting-edge diagnostic and interventional tool. These converging factors are accelerating the uptake of magnetic particle imaging solutions, thereby significantly boosting the industry's growth

Magnetic Particle Imaging Market Analysis

• Magnetic particle imaging, offering highly sensitive and quantitative imaging capabilities for a variety of biomedical applications, is becoming an increasingly vital component of modern medical diagnostics and research in both preclinical and clinical settings due to its enhanced image contrast, real-time tracking, and non-ionizing radiation
• The escalating demand for magnetic particle imaging (MPI) is primarily fueled by the widespread adoption of non-invasive diagnostic technologies, growing research into targeted drug delivery and cell tracking, and a rising preference for precise and quantitative imaging without the drawbacks of ionizing radiation
• North America dominates the magnetic particle imaging market, with the largest revenue share of 38.1% in 2024, characterized by a robust healthcare infrastructure, significant investment in research and development, and a strong presence of key industry players and academic institutions
• Asia-Pacific is expected to be the fastest-growing region in the magnetic particle imaging market during the forecast period, with a CAGR of 12.15%. This is due to increasing urbanization, rising disposable incomes, and a growing emphasis on early disease diagnosis and personalized medicine in countries such as China, Japan, and India
• MPI Scanner segment dominates the magnetic particle imaging market, with a market share of 55.7% in 2024, driven by the high capital investment required for these sophisticated imaging systems, which are the fundamental platforms for performing MPI

Report Scope and Magnetic Particle Imaging Market Segmentation 

Magnetic Particle Imaging Market Trends

“Advanced Data Analysis and Workflow Streamlining in Magnetic Particle Imaging”

• A significant and accelerating trend in the global magnetic particle imaging market is the deepening integration of advanced data analysis techniques, including machine learning and sophisticated algorithms, alongside a focus on streamlining imaging workflows. This fusion of technologies is significantly enhancing the precision, speed, and overall efficiency of diagnostic and research processes
  • For instance, real-time image reconstruction algorithms are being developed that allow for immediate visualization of magnetic nanoparticle distribution, eliminating post-processing delays. Similarly, automated segmentation tools are being integrated to quickly identify and quantify regions of interest within magnetic particle imaging datasets, significantly reducing manual analysis time for researchers and clinicians
• Advanced data analysis in magnetic particle imaging enables features such as learning optimal imaging parameters to potentially suggest improved acquisition protocols and providing more intelligent quantification of nanoparticle concentrations based on complex biological environments
• The seamless integration of magnetic particle imaging systems with laboratory information management systems (LIMS) and broader clinical imaging platforms facilitates centralized control over various aspects of the imaging process. Through a single interface, users can manage their imaging sequences alongside experimental data, patient records, and other analytical tools, creating a unified and automated research or clinical experience
• The demand for magnetic particle imaging solutions that offer seamless data analysis and workflow streamlining is growing rapidly across both preclinical research and emerging clinical sectors, as users increasingly prioritize efficiency, accuracy, and comprehensive imaging functionality

Magnetic Particle Imaging Market Dynamics

Driver

“Growing Need Due to Advancements in Biomedical Research and Diagnostic Demands”

• The increasing sophistication of biomedical research, particularly in areas such as cell therapy, targeted drug delivery, and cardiovascular diagnostics, coupled with the accelerating demand for highly sensitive and quantitative imaging, is a significant driver for the heightened demand for magnetic particle imaging (MPI)
  • For instance, in late 2023, several research groups reported breakthroughs in using magnetic nanoparticles to track immune cells in vivo with unprecedented sensitivity, demonstrating the technique's potential for monitoring disease progression and therapeutic efficacy. Such advancements in research applications are expected to drive the magnetic particle imaging industry growth in the forecast period
• As researchers and clinicians seek more precise and non-ionizing methods to visualize biological processes and therapeutic interventions, magnetic particle imaging offers advanced features such as real-time tracking, quantitative measurements of nanoparticle concentrations, and deep tissue penetration, providing a compelling upgrade over traditional imaging modalities such as  optical imaging or certain forms of MRI for specific applications
• Furthermore, the growing interest in personalized medicine and the desire for highly specific diagnostic tools are making magnetic particle imaging an integral component of preclinical studies and an emerging player in clinical translation, offering seamless integration with molecular biology techniques and advanced medical protocols.
• The convenience of direct, quantitative measurement of magnetic nanoparticles, the ability to track cells or drugs without background signal from tissue, and the potential for rapid image acquisition are key factors propelling the adoption of magnetic particle imaging in both academic research and pharmaceutical development. The trend towards multimodal imaging platforms and the increasing availability of sophisticated magnetic particle imaging systems further contributes to market growth

Restraint/Challenge

“Concerns Regarding High Initial System Costs and Limited Commercial Nanoparticle Availability”

• Concerns surrounding the substantial initial capital investment required for magnetic particle imaging systems and the limited commercial availability of specialized, clinically validated magnetic nanoparticles pose a significant challenge to broader market penetration. As magnetic particle imaging relies on sophisticated hardware and precisely engineered contrast agents, these factors raise anxieties among potential adopters about the economic viability and scalability of the technology
  • For instance, high-profile reports on the significant cost of establishing a new magnetic particle imaging facility have made some institutions hesitant to adopt this cutting-edge imaging solution, preferring more established and lower-cost alternatives
• Addressing these cost concerns through scalable system designs, strategic collaborations for shared resources, and increased investment in nanoparticle manufacturing is crucial for building broader market acceptance. Companies and research consortia are working towards developing more cost-effective magnetic particle imaging prototypes and expanding the production of high-quality magnetic nanoparticles to reassure potential buyers
• While advancements are gradually making the technology more accessible, the perceived high premium for this advanced imaging technology can still hinder widespread adoption, especially for those who do not yet see an immediate, critical need for its unique benefits over existing imaging modalities

Magnetic Particle Imaging Market Scope

The global magnetic particle imaging market is segmented into four key areas: type, modality, application, and end user.

• By Type

On the basis of type, the magnetic particle imaging market is segmented into tracer, MPI scanner, and others. The MPI scanner segment held the largest market revenue share of 55.7% in 2024. This dominance is driven by the high initial investment required for the imaging systems themselves, which are the core component of any magnetic particle imaging setup. The ongoing technological advancements and increasing complexity of these scanners also contribute to their significant market value.

The tracer segment is anticipated to witness the fastest growth rate from 2025 to 2032. This rapid growth is fueled by continuous research and development into novel, more sensitive, and application-specific magnetic nanoparticles, which are crucial for enhancing the capabilities and expanding the applications of magnetic particle imaging.

• By Modality

On the basis of modality, the magnetic particle imaging (MPI) market is segmented into Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET). The MRI segment held the largest market revenue share of 44.2% in 2024, owing to its widespread use in preclinical research, high-resolution anatomical imaging, and its established infrastructure across research institutions. Its compatibility with MPI for hybrid imaging applications further strengthens its dominance.

The Positron Emission Tomography (PET) segment is anticipated to witness the fastest growth rate from 2025 to 2032, driven by the rising demand for functional imaging and increasing adoption of hybrid systems such as PET/MPI and PET/CT. The ability of PET to offer real-time metabolic and molecular imaging makes it an attractive modality for expanding research and clinical diagnostics.

• By Application

On the basis of application, the magnetic particle imaging market is segmented into vascular imaging, perfusion imaging, blood pool imaging, neuroimaging, localized hyperthermia, oncology imaging, cell tracking, inflammation imaging, and trauma imaging. The Cell Tracking segment is held the largest market revenue share, driven by the immense potential of magnetic particle imaging in cancer research, monitoring targeted therapies, and tracking various cell types for therapeutic and diagnostic purposes.

The localized hyperthermia segment is anticipated to witness the fastest growth rate from 2025 to 2032, fueled by ongoing research into using magnetic nanoparticles for targeted heat delivery in cancer therapy, offering a non-invasive and highly precise treatment approach.

• By End User

On the basis of end user, the magnetic particle imaging market is segmented into hospitals and specialty clinics. The hospitals held the largest market revenue share in 2024. This is because magnetic particle imaging is still largely a part of healthcare unit.

The specialty clinics segment is anticipated to witness the fastest growth rate from 2025 to 2032. This growth is expected as magnetic particle imaging technology matures and gains clinical approval for specific diagnostic and therapeutic applications, leading to its gradual adoption in more specialized clinical settings for patient care.

Magnetic Particle Imaging Market Regional Analysis

• North America dominates the magnetic particle imaging market with a revenue share of 38.1% in 2024. This strong position is driven by its robust healthcare infrastructure, substantial investments in biomedical research and development, and a high adoption rate of advanced medical technologies
• Consumers and research institutions in the region highly value the precision, quantitative capabilities, and non-ionizing nature offered by magnetic particle imaging systems. This positions MPI as a cutting-edge tool for various applications, including cell tracking, targeted drug delivery, and early disease detection
• This widespread adoption is further supported by high research funding, a technologically advanced scientific community, and the growing preference for innovative diagnostic and therapeutic approaches. These factors firmly establish magnetic particle imaging as a favored solution for both preclinical research and emerging clinical applications across North America

U.S. Magnetic Particle Imaging Market Insight

The U.S. magnetic particle imaging market captured the largest revenue share of 75.4% in 2024 within North America. This growth is fueled by substantial investments in biomedical research and development, particularly in leading academic institutions and pharmaceutical companies. Researchers are increasingly prioritizing the enhancement of diagnostic precision and therapeutic monitoring through highly sensitive, non-ionizing imaging systems. The robust funding for cell therapy and targeted drug delivery research, combined with a strong demand for quantitative imaging insights, further propels the magnetic particle imaging industry. Moreover, the increasing integration of advanced AI algorithms for image reconstruction and analysis is significantly contributing to the market's expansion.

Europe Magnetic Particle Imaging Market Insight

The Europe magnetic particle imaging market is projected to expand at a substantial CAGR throughout the forecast period. This growth is primarily driven by strong government and EU-level funding for medical research, coupled with the escalating need for advanced preclinical and early clinical imaging solutions. The increase in collaborative research initiatives across European countries, coupled with a focus on translating novel technologies to clinical practice, is fostering the adoption of magnetic particle imaging. European research institutions are also drawn to the quantitative capabilities and safety profile (non-ionizing) these devices offer. The region is experiencing significant growth across academic research, pharmaceutical R&D, and emerging clinical diagnostic applications, with magnetic particle imaging being incorporated into both new research programs and advanced medical facilities.

U.K. Magnetic Particle Imaging Market Insight

U.K. magnetic particle imaging market is anticipated to grow at a noteworthy CAGR during the forecast period. This is driven by a escalating focus on advanced medical diagnostics and a desire for heightened precision in disease characterization and treatment monitoring. In addition, concerns regarding chronic diseases and the push for personalized medicine are encouraging both researchers and healthcare providers to explore cutting-edge imaging solutions. The UK’s robust scientific community, alongside its strong National Health Service (NHS) research infrastructure, is expected to continue to stimulate magnetic particle imaging market growth, especially in oncology, cardiology, and neurology research.

Germany Magnetic Particle Imaging Market Insight

The Germany magnetic particle imaging market is expected to expand at a considerable CAGR during the forecast period. This growth is fueled by increasing awareness of advanced medical technologies and the demand for highly quantitative and innovative diagnostic solutions. Germany’s well-developed research infrastructure, combined with its emphasis on engineering excellence and precision manufacturing in the medical device sector, promotes the adoption of magnetic particle imaging, particularly in university hospitals and dedicated research centers. The integration of magnetic particle imaging with multimodal imaging platforms is also becoming increasingly prevalent, with a strong preference for secure, data-rich solutions aligning with local scientific and clinical expectations.

Asia-Pacific Magnetic Particle Imaging Market Insight

The Asia-Pacific magnetic particle imaging market is poised to grow at the fastest CAGR of 12.15% during the forecast period of 2025 to 2032. This rapid expansion is driven by increasing healthcare expenditure, rising disposable incomes, and significant technological advancements in countries such as China, Japan, and India. The region's growing inclination towards advanced medical research, supported by government initiatives promoting medical innovation and R&D, is driving the adoption of magnetic particle imaging. Furthermore, as APAC emerges as a manufacturing hub for medical components and systems, the affordability and accessibility of magnetic particle imaging solutions are expanding to a wider research and clinical base.

Japan Magnetic Particle Imaging Market Insight

The Japan magnetic particle imaging market is gaining momentum due to the country’s high-tech culture, rapid advancements in medical science, and demand for precise diagnostic tools. The Japanese market places a significant emphasis on technological innovation and patient outcomes, and the adoption of magnetic particle imaging is driven by the increasing number of cutting-edge research facilities and a focus on addressing complex diseases. The integration of magnetic particle imaging with other molecular imaging techniques and advanced therapeutic platforms is fueling growth. Moreover, Japan's aging population is such as ly to spur demand for highly sensitive and non-invasive diagnostic solutions in both research and emerging clinical sectors.

China Magnetic Particle Imaging Market Insight

The China magnetic particle imaging market accounted for the largest market revenue share in Asia Pacific in 2024, estimated to be around 48% of the regional market. This is attributed to the country's massive government investment in scientific research, rapid expansion of advanced research institutions, and high rates of technological adoption in the medical field. China is becoming a significant player in medical imaging innovation, and magnetic particle imaging is becoming increasingly popular in universities, national laboratories, and large hospital research departments. The push towards establishing world-class research capabilities and the availability of increasingly sophisticated magnetic particle imaging systems, alongside strong domestic manufacturing capabilities, are key factors propelling the market in China.

Magnetic Particle Imaging Market Share

The magnetic particle imaging industry is primarily led by well-established companies, including:

• Bruker (U.S.)
• Magnetic Insight, Inc. (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Mediso Ltd. (Hungary)
• MILabs B.V. (Netherlands)
• Northridge Tri-Modality Imaging, Inc. (U.S.)
• General Electric Company (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• MR Solutions (U.K.)
• Mirion Technologies, Inc. (U.S.)
• Berthold Technologies GmbH & Co. KG (Germany)
• FUJIFILM Corporation (Japan)
• LI-COR Inc. (U.S.)
• Angstrom Advanced Inc. (U.S.)
• Pure Devices GmbH (Germany)
• Miltenyi Biotec (Germany)
• CMR Naviscan (U.S.)
• PerkinElmer (U.S.)  
• COMSOL (U.S.)

SKU-47819